In vivo studies have shown that Ag-DC-CIK therapy exhibits significant tumor suppression in gastric cancer xenografts, as evidenced by histopathological analysis indicating extensive necrosis and a reduction in Ki67+ proliferative cells. The gene discussed is MKI67; the disease is neoplasm.